Skip to main content

Multiple Myeloma (MM): Diagnosis, Treatment and Side Effects Management

Recorded on May 1, 2020

Click Here to Participate 

Format: Recorded Webinar
1.25 CE Credit Available Until: 
July 31, 2021

Target Audience

Nurse practitioners, nurses and oncology social workers involved in the care of patients with multiple myeloma.

Course Content Level for Social Workers: Intermediate and Advanced



This webinar will provide a basic overview of multiple myeloma, focusing on strategies for diagnosis and patient management. Risk assessment, treatment options, the role of various members of the healthcare team in addressing treatment goals, guidance for patients and caregivers in treatment decision making, as well as resources for patients, caregivers and healthcare providers will be discussed.


Learning Objectives

After completing this activity, participants should be better able to:

  • Describe an overview of multiple myeloma (MM)
  • Identify tests used to diagnose disease and monitor treatment of MM
  • Explain the overarching goals of treatment for MM
  • Explain approved and emerging treatment options for MM, including stem cell transplantation, and the role of clinical trials
  • Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for MM
  • Describe the roles of the pharmacist, the nurse and the social worker in treating patients with MM



Sagar Lonial,  MD
Chair and Professor 
Department of Hematology and Medical Oncology
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine 
Atlanta, GA
Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute
Emory Healthcare
Atlanta, GA
Charise Gleason, MSN, NP-BC, AOCNP®
Nurse Practitioner
Chief Advanced Practice Provider
Winship Cancer Institute
Emory University 
Adjunct Faculty 
Nell Hodgson Woodruff School of Nursing 
Atalanta, GA

Continuing Education

Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.25 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved as ACE providers. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. LLS maintains responsibility for this course. ACE provider approval period: 12/10/17-12/14/2020. Social workers completing this course receive 1.25 continuing education credits.

The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.25 clinical CE contact hours for this activity.

Participants must attend the free webinar in its entirety, submit the online evaluation form, and complete and submit the online post-test with a passing score of 70% to earn credit. Once submitted, the certificate will be automatically generated as a PDF online.



This program is provided by The Leukemia & Lymphoma Society.


Click Here to Participate

Participants gain access to the webinar via the registration button above. To view system requirements for this program, please click here.

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at


< Back to Continuing Education